alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › immunization

immunization

5 studies tagged immunization, dated 2012-02-01 to 2016-12-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Vectored Intracerebral Immunization with the Anti-Tau Monoclonal Antibody PHF1 Markedly Reduces Tau Pathology in Mutant Tau Transgenic Mice 2016-12-01
  2. Tau immunization: a cautionary tale? 2014-12-30
  3. Anti-amyloid beta to tau - based immunization: Developments in immunotherapy for Alzheimer disease 2013-08-01

Studies

5 studies carry this tag.

Date range

2012 to 2016

Top journals

  • Experimental neurology 1
  • ImmunoTargets and therapy 1
  • Immunotherapy 1
  • Neurobiology of aging 1
  • The Journal of neuroscience : the official journal of the Society for Neuroscience 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Vectored Intracerebral Immunization with the Anti-Tau Monoclonal Antibody PHF1 Markedly Reduces Tau Pathology in Mutant Tau Transgenic Mice

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. The Journal of neuroscience : the official journal of the Society for Neuroscience 2016-12-01 Drug development

    Passive immunization with anti-tau monoclonal antibodies has been shown by several laboratories to reduce age-dependent tau pathology and neurodegeneration in mutant tau transgenic mice.

  2. Tau immunization: a cautionary tale?

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Neurobiology of aging 2014-12-30 Drug development

    The amyloid β (Aβ)-protein and microtubule-associated protein, tau, are the major components of the amyloid plaques and neurofibrillary tangles that typify Alzheimer's disease (AD) pathology.

  3. Anti-amyloid beta to tau - based immunization: Developments in immunotherapy for Alzheimer disease

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. ImmunoTargets and therapy 2013-08-01 Drug development

    Immunotherapy might provide an effective treatment for Alzheimer disease (AD).

  4. Repeated immunization of mice with phosphorylated-tau peptides causes neuroinflammation

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Experimental neurology 2013-07-20 Drug development

    The recent studies of others and of us showing robust efficacy of anti-tangle immunotherapy, directed against phosphorylated (phos)-tau protein, may pave the way to clinical trials of phos-tau immunotherapy in Alzheimer's-disease and other tauopathies.

  5. Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Immunotherapy 2012-02-01 Treatments

    The exact mechanisms leading to Alzheimer's disease (AD) are largely unknown, limiting the identification of effective disease-modifying therapies.

All topic tags with their study counts